NO20074036L - Anvendelse av cyaninfargestoffer for diagnose av proliferative sykdommer - Google Patents

Anvendelse av cyaninfargestoffer for diagnose av proliferative sykdommer

Info

Publication number
NO20074036L
NO20074036L NO20074036A NO20074036A NO20074036L NO 20074036 L NO20074036 L NO 20074036L NO 20074036 A NO20074036 A NO 20074036A NO 20074036 A NO20074036 A NO 20074036A NO 20074036 L NO20074036 L NO 20074036L
Authority
NO
Norway
Prior art keywords
diagnosis
cyanine dyes
proliferative diseases
diseases
administration
Prior art date
Application number
NO20074036A
Other languages
English (en)
Inventor
Kai Licha
Michael Schirner
Martin Pessel
Malte Bahner
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34933224&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20074036(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of NO20074036L publication Critical patent/NO20074036L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0032—Methine dyes, e.g. cyanine dyes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0032—Methine dyes, e.g. cyanine dyes
    • A61K49/0034—Indocyanine green, i.e. ICG, cardiogreen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0058—Antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

Foreliggende oppfinnelse gjelder anvendelse av cyaninfargestofifet SF64 for diagnose av prohferative sykdommer etter tilførsel av mindre enn 5 mg/kg kroppsvekt.
NO20074036A 2005-01-07 2007-08-03 Anvendelse av cyaninfargestoffer for diagnose av proliferative sykdommer NO20074036L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05000276A EP1679082A1 (en) 2005-01-07 2005-01-07 Use of cyanine dyes for the diagnosis of proliferative diseases
PCT/EP2006/000058 WO2006072580A1 (en) 2005-01-07 2006-01-05 Use of cyanine dyes for the diagnosis of proliferative diseases

Publications (1)

Publication Number Publication Date
NO20074036L true NO20074036L (no) 2007-08-03

Family

ID=34933224

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20074036A NO20074036L (no) 2005-01-07 2007-08-03 Anvendelse av cyaninfargestoffer for diagnose av proliferative sykdommer

Country Status (23)

Country Link
EP (2) EP1679082A1 (no)
JP (1) JP5578765B2 (no)
KR (1) KR20070092270A (no)
CN (1) CN101128218A (no)
AR (1) AR052190A1 (no)
AU (1) AU2006204496A1 (no)
BR (1) BRPI0606411A2 (no)
CA (1) CA2594390C (no)
CR (1) CR9232A (no)
DO (1) DOP2006000005A (no)
GT (1) GT200600001A (no)
IL (1) IL182499A0 (no)
MX (1) MX2007008300A (no)
NO (1) NO20074036L (no)
NZ (1) NZ554917A (no)
PA (1) PA8659101A1 (no)
PE (2) PE20100449A1 (no)
RU (1) RU2007129919A (no)
TW (1) TW200635612A (no)
UA (1) UA89976C2 (no)
UY (1) UY29323A1 (no)
WO (1) WO2006072580A1 (no)
ZA (1) ZA200706533B (no)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE374367T1 (de) * 2004-07-22 2007-10-15 Bayer Schering Pharma Ag Verwendung von cyanin-farbstoffen zur diagnose von krankheiten, welche mit angiogenese assoziert sind
EP1679082A1 (en) * 2005-01-07 2006-07-12 Schering AG Use of cyanine dyes for the diagnosis of proliferative diseases
EP1743658A1 (en) * 2005-07-14 2007-01-17 Schering Aktiengesellschaft Optical imaging of rheumatoid arthritis
WO2008119493A1 (en) * 2007-03-30 2008-10-09 F. Hoffmann-La Roche Ag Composition of labeled and non-labeled monoclonal antibodies
WO2009012109A2 (en) 2007-07-13 2009-01-22 Emory University Cyanine-containing compounds for cancer imaging and treatment
GB0803477D0 (en) 2008-02-26 2008-04-02 Ge Healthcare As Therapy selection method
WO2009152440A1 (en) * 2008-06-13 2009-12-17 Cedars-Sinai Medical Center Small molecule ligand-drug conjugates for targeted cancer therapy
GB0814960D0 (en) * 2008-08-15 2008-09-24 Ge Healthcare As Method for detecting dysplasia
CA2766861A1 (en) 2009-07-09 2011-01-13 F. Hoffmann-La Roche Ag In vivo tumor vasculature imaging
WO2011012646A2 (en) 2009-07-28 2011-02-03 F. Hoffmann-La Roche Ag Non-invasive in vivo optical imaging method
JP2011046663A (ja) 2009-08-28 2011-03-10 Fujifilm Corp 近赤外蛍光造影剤
JP2011046662A (ja) 2009-08-28 2011-03-10 Fujifilm Corp 近赤外蛍光造影剤
WO2011025950A2 (en) 2009-08-28 2011-03-03 Visen Medical, Inc. Systems and methods for tomographic imaging in diffuse media using a hybrid inversion technique
WO2011038006A1 (en) 2009-09-22 2011-03-31 Visen Medical, Inc. Systems and methods for virtual index-matching of diffusive media
KR20130036012A (ko) 2010-05-07 2013-04-09 에프. 호프만-라 로슈 아게 생체외 세포의 검출을 위한 진단 방법
WO2012119999A1 (en) 2011-03-07 2012-09-13 F. Hoffmann-La Roche Ag Means and methods for in vivo testing of therapeutic antibodies
EP2683413A1 (en) 2011-03-07 2014-01-15 F.Hoffmann-La Roche Ag In vivo selection of therapeutically active antibodies
KR101373108B1 (ko) 2012-01-20 2014-03-27 이화여자대학교 산학협력단 폴리메틴 체인에 메조-반응작용기를 갖는 신규한 시아닌 유도체 및 이의 제조방법
CN102608051B (zh) * 2012-02-21 2015-04-08 中国科学院化学研究所 用于诊断白血病的试剂盒
CN102703569B (zh) * 2012-05-24 2014-04-09 中国科学院化学研究所 菁染料的新用途
CN102706787B (zh) * 2012-05-24 2015-04-08 中国科学院化学研究所 菁染料的新用途
US10743768B2 (en) 2012-10-15 2020-08-18 Visen Medical, Inc. Systems, methods, and apparatus for imaging of diffuse media featuring cross-modality weighting of fluorescent and bioluminescent sources
US20150182518A1 (en) * 2012-10-26 2015-07-02 Canon Kabushiki Kaisha Cancer cell inhibitory drug and cancer stem-cell detection probe
US20150367004A1 (en) * 2012-12-10 2015-12-24 Molecular Targeting Technologies, Inc. Compositions and methods of diagnosing ocular diseases
AU2014373656B2 (en) 2013-12-31 2019-12-05 Cornell University Systems, methods, and apparatus for multichannel imaging of fluorescent sources in real time
RU2565645C1 (ru) * 2014-09-05 2015-10-20 Федеральное государственное бюджетное учреждение "Ростовский научно-исследовательский онкологический институт" Министерства здравоохранения Российской Федерации Способ рентгендиагностики глубины инвазии рецидива рака вульвы в мягкие ткани
WO2016100340A1 (en) 2014-12-15 2016-06-23 Memorial Sloan Kettering Cancer Center Cyclic peptides with enhanced nerve-binding selectivity, nanoparticles bound with said cyclic peptides, and use of same for real-time in vivo nerve tissue imaging
EP3389726A1 (en) 2015-12-15 2018-10-24 Memorial Sloan Kettering Cancer Center Imaging systems and methods for tissue differentiation, e.g., for intraoperative visualization
KR20190090394A (ko) 2016-11-30 2019-08-01 메모리얼 슬로안 케터링 캔서 센터 억제제-작용화된 초소형 나노입자 및 이의 방법
CA3095410A1 (en) 2018-03-30 2019-10-03 Perkinelmer Health Sciences, Inc. Systems and methods for 3d reconstruction of anatomical organs and inclusions using short-wave infrared (swir) projection tomography
JP2022053289A (ja) * 2020-09-24 2022-04-05 大塚製薬株式会社 シアニン系色素、標識試薬および検出方法
EP4015004A1 (en) 2020-12-18 2022-06-22 Phi Pharma SA Proteoglycan specific branched peptides

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000095758A (ja) * 1998-09-18 2000-04-04 Schering Ag 近赤外蛍光造影剤および蛍光造影方法
DE19917713A1 (de) * 1999-04-09 2000-10-19 Diagnostikforschung Inst Kurzkettige Peptid-Farbstoffkonjugate als Konstrastmittel für die optische Diagnostik
DE19947559A1 (de) * 1999-09-24 2001-04-19 Schering Ag Antikörper-Farbstoffkonjugate gegen Zielstrukturen der Angiogenese zur intraoperativen Tumorranddarstellung
MXPA05007668A (es) * 2003-01-24 2005-09-30 Schering Ag Colorantes hidrofilicos de cianina, reactivos a tiol y conjugados de los mismos con biomoleculas para diagnostico por fluorescencia.
ATE374367T1 (de) * 2004-07-22 2007-10-15 Bayer Schering Pharma Ag Verwendung von cyanin-farbstoffen zur diagnose von krankheiten, welche mit angiogenese assoziert sind
EP1679082A1 (en) * 2005-01-07 2006-07-12 Schering AG Use of cyanine dyes for the diagnosis of proliferative diseases

Also Published As

Publication number Publication date
PE20060872A1 (es) 2006-10-01
RU2007129919A (ru) 2009-02-20
EP1679082A1 (en) 2006-07-12
CN101128218A (zh) 2008-02-20
JP2008526802A (ja) 2008-07-24
GT200600001A (es) 2006-08-22
CA2594390C (en) 2013-10-22
AU2006204496A1 (en) 2006-07-13
CR9232A (es) 2007-11-23
NZ554917A (en) 2010-01-29
MX2007008300A (es) 2007-09-07
PE20100449A1 (es) 2010-07-25
DOP2006000005A (es) 2006-07-15
EP1833513B1 (en) 2013-03-06
WO2006072580A1 (en) 2006-07-13
ZA200706533B (en) 2009-07-29
JP5578765B2 (ja) 2014-08-27
EP1833513A1 (en) 2007-09-19
UA89976C2 (ru) 2010-03-25
CA2594390A1 (en) 2006-07-13
AR052190A1 (es) 2007-03-07
KR20070092270A (ko) 2007-09-12
TW200635612A (en) 2006-10-16
UY29323A1 (es) 2006-10-02
PA8659101A1 (es) 2006-09-08
IL182499A0 (en) 2007-09-20
BRPI0606411A2 (pt) 2009-06-23

Similar Documents

Publication Publication Date Title
NO20074036L (no) Anvendelse av cyaninfargestoffer for diagnose av proliferative sykdommer
HN2008000360A (es) Dispersiones amorfas solidas
EP1732602A4 (en) CYTOTOXICITY TRANSFER OF CELLS WITH NOTES ON SURFACE EXPRESSION OF MCSP
WO2011045415A3 (en) Imaging agents and their use for the diagnostic in vivo of neurodegenerative diseases, notably alzheimer's disease and derivative diseases
DE60323766D1 (de) En konjugate mit biomolekülen für fluoreszenzdiagnose
CL2008001303A1 (es) Compuestos derivados de heterociclos, moduladores de gamma secretasa; composicion farmaceutica; kit farmaceutico; y uso en el tratamiento del alzheimer.
ECSP10010599A (es) Derivados de tienopiridonas como activadores de proteina quinasa activados por amp (ampk)
WO2009149485A3 (en) Compounds for treating amyloidoses
EA201070804A1 (ru) (аза)индольное производное, замещенное по положению 5, содержащая его фармацевтическая композиция, промежуточные соединения и способ их получения
CR10842A (es) Derivados de acetileno y su uso para la union a placas amiloides y su diagnostico por imagenes
WO2007088129A3 (en) Cyanine dye compounds linked to metal chelator for bi-modal diagnostic imaging
DE602006006712D1 (de) Thiazolylpiperidin-derivate nützlich als h3 rezeptor modulatoren
PL1765863T3 (pl) Związki oparte na peptydach
EP2365974A4 (en) FLUORATED BENZOTHIAZOL DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND IMAGE-DISPLAYING AGENT FOR THE DIAGNOSIS OF ALZHEIMER DISEASE, WHICH USES THEREOF
MX2009009469A (es) Nuevos benzotiofenos y benzofuranos sustituidos en la posicion 2 con heteroarilo 709.
TW200613733A (en) Use of cyanine dyes for the diagnosis of disease associated with angiogenesis
WO2004100998A3 (en) Compositions and methods for non-invasive imaging of soluble beta-amyloid
NO20056055L (no) Fluorescein-labelled peptides
BRPI0518613A2 (pt) compostos, composiÇço farmacÊutica, mÉtodo de preparar uma composiÇço, e, uso de um composto
TW200637817A (en) 5-aminoindole derivatives
MX2009009113A (es) Nuevos indoles 2-heteroaril sustituidos 695.
JP2008509921A5 (no)
BRPI0516057A (pt) derivados de indol como inibidores da ciclase de adenilato solúvel
RU2004137240A (ru) 3, 4, 17, 18-дициклопента[c, d]фенален-2, 5, 6,15, 16, 19-тетрагидро-1h-7, 10, 11, 14, 21, 24, 25, 28-тетрафенилен-2, 2`-9, 12, 23, 26-тетрасульфо-[c, m]-[1, 6, 15, 20]-тетраазациклооктакозан[2, 3, 4, 5, 7, 10, 11, 14, 16, 17, 18, 19, 21, 24, 25, 28], обладающий свойством кислотного красителя для шелка и шерсти
RU2005111872A (ru) Антитромботическое, антикоагулянтное, фибриндеполимеризационное, фибринолитическое средство

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application